otherRIA · CRD 158620SEC-Registered

Updated:

Kamada Ltd.

Kamada Ltd. is an SEC-registered investment adviser with approximately $10 million in regulatory assets under management. The firm has 1 employee and 1...

Kamada Ltd.

Kamada Ltd. is an SEC-registered investment adviser with approximately $10 million in regulatory assets under management. The firm has 1 employee and 1 investment adviser. It operates with a small team.

Website
kamada.com

General information

Firm type

Public Company

Location

Region

Middle East

Country

Israel

City

Rehovot

Corporate office

Rehovot, Israel

Sector focus

Healthcare ServicesBiotech

Frequently asked questions

Who runs investment decisions at Kamada?

Kamada is a publicly traded company, not a family office. Investment decisions are made by its board of directors and executive management. The firm does not publicly name a single controlling principal or family foundation. (per company filings)

How does Kamada source proprietary deal flow?

Kamada is a biopharmaceutical company, not an investment firm. Its pipeline is primarily internally developed rather than sourced via external investments. The firm's competitive position rests on its plasma purification platform and approved products.

Is Kamada structured as a family office or a venture firm?

Neither. Kamada is a public biopharmaceutical company, traded on the Tel Aviv Stock Exchange and NASDAQ. It operates as a drug developer and manufacturer, not as an investment vehicle.

Does Kamada participate in fund commitments or only direct deals?

Kamada does not make fund commitments. As an operating company, its capital allocation focuses on R&D, manufacturing, and commercial activities in plasma-derived therapeutics.

What investment stages does Kamada typically target?

Kamada does not invest externally. It develops and markets its own proprietary therapeutics, with a pipeline ranging from preclinical through commercial-stage products.

Which sectors does Kamada explicitly avoid?

Kamada focuses solely on plasma-derived biologics. It does not participate in small molecules, gene therapy, or other modalities outside its core platform.

Where does the underlying wealth come from?

Kamada is a publicly traded company with no disclosed single-family wealth origin. Its shareholders are institutional and retail investors.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on registered investment advisers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Rehovot Public Company profiles